maleimide has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shakarchi, W; Albusair, MK; Aldebasi, MH; Curtis, ADM; Elsini, RS; Haxton, KJ; Hoskins, C; Manzur, A; Oluwasanmi, A | 1 |
| Koga, Y; Manabe, S; Matsumura, Y; Takashima, H; Tsumura, R; Yasunaga, M | 1 |
2 other study(ies) available for maleimide and Cancer of Pancreas
| Article | Year |
|---|---|
Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Liberation; Female; Gemcitabine; Hot Temperature; Humans; Lasers; Maleimides; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Prodrugs; Tumor Burden | 2017 |
Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft models.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Immunological; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Administration Schedule; Female; Humans; Immunoconjugates; Maleimides; Mice; Mice, Transgenic; Pancreatic Neoplasms; Rats; Stromal Cells; Thromboplastin; Xenograft Model Antitumor Assays | 2019 |